Skip to main content
Livermore
Livermore
ZHEN

Baker Bros. Advisors LP

SEC CIK
0001263508
Latest filing
Aug 14, 2026

EWTX holding history

Edgewise Therapeutics, Inc. in every 13F filed by Baker Bros. Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EWTX overviewAll 13F holders of EWTXFull Q2 2026 holdings

Shares (Q2 2026)
3,701,719
Value
$150.4M
% of portfolio
0.8%
Quarters held
22
Since Q1 2021
Holdings of EWTX by Baker Bros. Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,701,719$150.4M0.8%−2,874,221−43.7%ReducedHolders
Q1 20266,575,940$207.1M1.2%00.0%UnchangedHolders
Q4 20256,575,940$163.2M1.0%−730,000−10.0%ReducedHolders
Q3 20257,305,940$118.5M0.9%00.0%UnchangedHolders
Q2 20257,305,940$95.8M0.9%+1,150,000+18.7%AddedHolders
Q1 20256,155,940$135.4M1.5%00.0%UnchangedHolders
Q4 20246,155,940$164.4M1.8%+315,881+5.4%AddedHolders
Q3 20245,840,059$155.9M1.6%00.0%UnchangedHolders
Q2 20245,840,059$105.2M1.3%00.0%UnchangedHolders
Q1 20245,840,059$106.5M1.3%+2,727,273+87.6%AddedHolders
Q4 20233,112,786$34.1M0.4%+2,063,087+196.5%AddedHolders
Q3 20231,049,699$6.01M<0.1%+549,699+109.9%AddedHolders
Q2 2023500,000$3.88M<0.1%00.0%UnchangedHolders
Q1 2023500,000$3.33M<0.1%00.0%UnchangedHolders
Q4 2022500,000$4.47M<0.1%00.0%UnchangedHolders
Q3 2022500,000$4.92M<0.1%00.0%UnchangedHolders
Q2 2022500,000$3.98M<0.1%00.0%UnchangedHolders
Q1 2022500,000$4.85M<0.1%00.0%UnchangedHolders
Q4 2021500,000$7.64M<0.1%00.0%UnchangedHolders
Q3 2021500,000$8.30M<0.1%00.0%UnchangedHolders
Q2 2021500,000$10.7M<0.1%00.0%UnchangedHolders
Q1 2021500,000$16.3M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.